Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer

Michael J. Flister, Shirng Wern Tsaih, Alexander Stoddard, Cody Plasterer, Jaidip Jagtap, Abdul K. Parchur, Gayatri Sharma, Anthony R. Prisco, Angela Lemke, Dana Murphy, Mona Al-Gizawiy, Michael Straza, Sophia Ran, Aron M. Geurts, Melinda R. Dwinell, Andrew S. Greene, Carmen Bergom, Peter S. LaViolette, Amit Joshi

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Purpose: Multiple aspects of the tumor microenvironment (TME) impact breast cancer, yet the genetic modifiers of the TME are largely unknown, including those that modify tumor vascular formation and function. Methods: To discover host TME modifiers, we developed a system called the Consomic/Congenic Xenograft Model (CXM). In CXM, human breast cancer cells are orthotopically implanted into genetically engineered consomic xenograft host strains that are derived from two parental strains with different susceptibilities to breast cancer. Because the genetic backgrounds of the xenograft host strains differ, whereas the inoculated tumor cells are the same, any phenotypic variation is due to TME-specific modifier(s) on the substituted chromosome (consomic) or subchromosomal region (congenic). Here, we assessed TME modifiers of growth, angiogenesis, and vascular function of tumors implanted in the SSIL2Rγ and SS.BN3IL2Rγ CXM strains. Results: Breast cancer xenografts implanted in SS.BN3IL2Rγ (consomic) had significant tumor growth inhibition compared with SSIL2Rγ (parental control), despite a paradoxical increase in the density of blood vessels in the SS.BN3IL2Rγ tumors. We hypothesized that decreased growth of SS.BN3IL2Rγ tumors might be due to nonproductive angiogenesis. To test this possibility, SSIL2Rγ and SS.BN3IL2Rγ tumor vascular function was examined by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), micro-computed tomography (micro-CT), and ex vivo analysis of primary blood endothelial cells, all of which revealed altered vascular function in SS.BN3IL2Rγ tumors compared with SSIL2Rγ. Gene expression analysis also showed a dysregulated vascular signaling network in SS.BN3IL2Rγ tumors, among which DLL4 was differentially expressed and co-localized to a host TME modifier locus (Chr3: 95–131 Mb) that was identified by congenic mapping. Conclusions: Collectively, these data suggest that host genetic modifier(s) on RNO3 induce nonproductive angiogenesis that inhibits tumor growth through the DLL4 pathway.

Original languageEnglish (US)
Pages (from-to)53-64
Number of pages12
JournalBreast Cancer Research and Treatment
Volume165
Issue number1
DOIs
StatePublished - Aug 1 2017

    Fingerprint

Keywords

  • Breast cancer
  • Genomics
  • Imaging
  • RNA sequencing
  • Tumor microenvironment

Cite this

Flister, M. J., Tsaih, S. W., Stoddard, A., Plasterer, C., Jagtap, J., Parchur, A. K., Sharma, G., Prisco, A. R., Lemke, A., Murphy, D., Al-Gizawiy, M., Straza, M., Ran, S., Geurts, A. M., Dwinell, M. R., Greene, A. S., Bergom, C., LaViolette, P. S., & Joshi, A. (2017). Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. Breast Cancer Research and Treatment, 165(1), 53-64. https://doi.org/10.1007/s10549-017-4311-8